Korea Investment Corp’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69M Buy
178,295
+74,110
+71% +$27.5M 0.13% 141
2026
Q1
$30.5M Sell
104,185
-31,162
-23% -$10.2M 0.06% 279
2025
Q4
$47.4M Sell
135,347
-21,635
-14% -$7.31M 0.09% 199
2025
Q3
$50.7M Sell
156,982
-16,113
-9% -$5.01M 0.1% 186
2025
Q2
$67.3M Buy
173,095
+16,939
+11% +$6.81M 0.15% 132
2025
Q1
$67.9M Buy
156,156
+932
+0.6% +$374K 0.16% 116
2024
Q4
$57.3M Sell
155,224
-140
-0.1% -$58.6K 0.14% 143
2024
Q3
$80.8M Sell
155,364
-5,237
-3% -$2.8M 0.19% 112
2024
Q2
$87M Sell
160,601
-51,461
-24% -$27.2M 0.22% 94
2024
Q1
$110M Sell
212,062
-23,377
-10% -$11.6M 0.28% 71
2023
Q4
$111M Sell
235,439
-13,712
-6% -$6.34M 0.29% 73
2023
Q3
$108M Buy
249,151
+25,767
+12% +$11.7M 0.32% 62
2023
Q2
$99.2M Sell
223,384
-13,556
-6% -$6.25M 0.28% 77
2023
Q1
$109M Sell
236,940
-18,024
-7% -$8.58M 0.32% 73
2022
Q4
$131M Sell
254,964
-2,780
-1% -$1.41M 0.41% 50
2022
Q3
$117M Sell
257,744
-12,223
-5% -$5.85M 0.36% 61
2022
Q2
$130M Buy
269,967
+32,051
+13% +$15.9M 0.4% 56
2022
Q1
$117M Buy
237,916
+28,368
+14% +$13M 0.29% 88
2021
Q4
$97.1M Buy
209,548
+48,116
+30% +$20.2M 0.25% 110
2021
Q3
$60.2M Sell
161,432
-34,239
-17% -$13M 0.18% 141
2021
Q2
$74.7M Buy
195,671
+17,626
+10% +$6.74M 0.21% 128
2021
Q1
$63.9M Sell
178,045
-8,962
-5% -$2.88M 0.2% 139
2020
Q4
$60M Sell
187,007
-417
-0.2% -$128K 0.18% 147
2020
Q3
$50.3M Sell
187,424
-6,700
-3% -$1.8M 0.18% 157
2020
Q2
$51.1M Sell
194,124
-23,300
-11% -$6.22M 0.19% 143
2020
Q1
$49.4M Sell
217,424
-26,400
-11% -$7.19M 0.22% 128
2019
Q4
$73.6M Buy
243,824
+23,200
+11% +$6.38M 0.27% 98
2019
Q3
$53M Buy
220,624
+13,000
+6% +$3.56M 0.22% 119
2019
Q2
$58.6M Buy
207,624
+14,900
+8% +$4.07M 0.25% 99
2019
Q1
$55.3M Buy
192,724
+12,133
+7% +$3.51M 0.25% 102
2018
Q4
$47.4M Sell
180,591
-13,800
-7% -$3.79M 0.26% 93
2018
Q3
$53.3M Sell
194,391
-34,478
-15% -$8.95M 0.25% 105
2018
Q2
$54.5M Sell
228,869
-83,000
-27% -$19.2M 0.25% 107
2018
Q1
$68.5M Sell
311,869
-9,076
-3% -$2.13M 0.32% 80
2017
Q4
$72.2M Buy
320,945
+13,900
+5% +$2.96M 0.33% 75
2017
Q3
$58.3M Sell
307,045
-12,600
-4% -$2.4M 0.27% 89
2017
Q2
$60.1M Buy
319,645
+202,435
+173% +$36.4M 0.28% 81
2017
Q1
$19.4M Sell
117,210
-5,801
-5% -$923K 0.1% 214
2016
Q4
$17.7M Sell
123,011
-6,689
-5% -$896K 0.09% 221
2016
Q3
$16.3M Buy
129,700
+10,400
+9% +$1.34M 0.09% 236
2016
Q2
$15.7M Hold
119,300
0.09% 229
2016
Q1
$16.6M Buy
119,300
+28,200
+31% +$3.77M 0.12% 189
2015
Q4
$12.7M Sell
91,100
-400
-0.4% -$55.1K 0.09% 220
2015
Q3
$12.8M Buy
91,500
+50,300
+122% +$7.56M 0.1% 213
2015
Q2
$6.76M Hold
41,200
0.06% 320
2015
Q1
$6.36M Buy
41,200
+2,800
+7% +$399K 0.05% 337
2014
Q4
$4.83M Sell
38,400
-31,700
-45% -$3.92M 0.04% 342
2014
Q3
$8.38M Sell
70,100
-53,400
-43% -$6.12M 0.07% 258
2014
Q2
$13.3M Sell
123,500
-10,800
-8% -$1.11M 0.11% 197
2014
Q1
$13.4M Sell
134,300
-34,300
-20% -$3.1M 0.12% 203
2013
Q4
$15.6M Buy
168,600
+16,000
+10% +$1.42M 0.15% 151
2013
Q3
$12.8M Sell
152,600
-217,300
-59% -$18.6M 0.14% 173
2013
Q2
$30.3M Buy
+369,900
New +$27.7M 0.36% 61

Other funds holding ELV

Korea Investment Corp's ELV Position: Q2 2026 in Review

Korea Investment Corp increased its Elevance Health (ELV) stake by 71% in Q2 2026, buying an estimated $27.5M and bringing the position to 178,295 shares worth $69M. The position accounts for 0.13% of the portfolio, ranked #141.

Korea Investment Corp first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $131M in Q4 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Korea Investment Corp held 178,295 shares of Elevance Health worth $69M as of Q2 2026.
  • Korea Investment Corp bought 74,110 Elevance Health shares in Q2 2026, an estimated $27.5M.
  • Elevance Health made up 0.13% of Korea Investment Corp's portfolio in Q2 2026, its #141 holding.
  • Korea Investment Corp first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • Korea Investment Corp's Elevance Health position peaked at $131M in Q4 2022.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Korea Investment Corp's 13F filing for Q2 2026, filed 12 Aug 2026.